References
- de Haas M, Finning K, Massey E, et al. Anti-D prophylaxis: past, present and future. Transfus Med. 2014;24:1–7.
- McBain RD, Crowther CA, Middleton P. Anti-D administration in pregnancy for preventing Rhesus alloimmunisation. Cochrane Database Syst Rev. 2015;3:Cd000020.
- Kornstad L. Fifteen years' experience with post-partum Rh prophylaxis in Norway (1969–83): incidence of new cases of anti-D and other clinically important blood group antibodies in pregnant women. NIPH Ann. 1987;1:3–10.
- Koelewijn JM, de Haas M, Vrijkotte TG, et al. One single dose of 200 µg of antenatal RhIG halves the risk of anti-D immunization and hemolytic disease of the fetus and newborn in the next pregnancy. Transfusion (Paris). 2008;48:1721–1729.
- Klein HG, Anstee DJ. Mollison’s blood transfusion in clinical medicine. 12th ed. Somerset (NJ): Wiley; 2014. Chapter 12, Haemolytic disease of the fetus and the newborn; p. 499–548.
- Lo YM, Hjelm NM, Fidler C, et al. Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma. N Engl J Med. 1998;339:1734–1738.
- Chitty LS, Finning K, Wade A, et al. Diagnostic accuracy of routine antenatal determination of fetal RHD status across gestation: population based cohort study. BMJ. 2014;349:g5243.
- Wikman AT, Tiblad E, Karlsson A, et al. Noninvasive single-exon fetal RHD determination in a routine screening program in early pregnancy. Obstet Gynecol. 2012;120:227–234.
- Haimila K, Sulin K, Kuosmanen M, et al. Targeted antenatal anti-D prophylaxis program for RhD-negative pregnant women – outcome of the first two years of a national program in Finland. Acta Obstet Gynecol Scand. 2017;96:1228–1233.
- Clausen FB, Steffensen R, Christiansen M, et al. Routine noninvasive prenatal screening for fetal RHD in plasma of RhD-negative pregnant women -2 years of screening experience from Denmark. Prenat Diagn. 2014;34:1000–1005.
- de Haas M, Thurik FF, van der Ploeg CP, et al. Sensitivity of fetal RHD screening for safe guidance of targeted anti-D immunoglobulin prophylaxis: prospective cohort study of a nationwide programme in the Netherlands. BMJ. 2016;355:i5789.
- Harm-Gerd KB, Husebekk A, Haugen G, et al. Immunisering [Immunisation]. In: Øian P, Flem Jacobsen A, Kessler J, editors. Veileder i fødselshjelp 2014 [Guidelines for Obstetrics 2014] (in Norwegian). Oslo: Norwegian Society of Gynecology and Obstetrics; 2014.
- Foster PR, McIntosh RV, Welch AG. Hepatitis C infection from anti-D immunoglobulin. Lancet. 1995;346:372.
- Clausen FB, Krog GR, Rieneck K, et al. Reliable test for prenatal prediction of fetal RhD type using maternal plasma from RhD negative women. Prenat Diagn. 2005;25:1040–1044.
- Clausen FB, Krog GR, Rieneck K, et al. Evaluation of two real-time multiplex PCR screening assays detecting fetal RHD in plasma from RhD negative women to ascertain the requirement for antenatal RhD prophylaxis. Fetal Diagn Ther. 2011;29:155–163.
- Wagner FF, Frohmajer A, Flegel WA. RHD positive haplotypes in D negative Europeans. BMC Genet. 2001;2:10
- Scheffer PG, de Haas M, van der Schoot CE. The controversy about controls for fetal blood group genotyping by cell-free fetal DNA in maternal plasma. Curr Opin Hematol. 2011; 18:467–473.
- Heier HE, Berge LN, Hervig T, et al. Immunisering i svangerskapet [Immunization in pregnancy]. Tidsskr nor Laegeforen. 2009;129:2016–2018. Norwegian.